An international study led by the University of Oulu's researchers reports five new genetic loci predisposing to atopic dermatitis. Based on three extensive biobanks, the study helps to understand the pathogenic mechanisms ...
Sep 17, 2021
0
12
(HealthDay)—Atopic dermatitis, a family history of psoriasis, and skin viral and bacterial infection and fungal infections in early life are associated with pediatric psoriasis development, according to a study published ...
Aug 24, 2021
0
3
(HealthDay)—Asking people about a history of psoriasis may be useful for assessing psoriasis prevalence, but a similar questionnaire assessing atopic dermatitis does not appear to be as reliable of a method, according to ...
Jul 14, 2021
0
1
The findings of a clinical trial by Trinity College Dublin researchers of treatment for atopic dermatitis have been published today in The Lancet journal (Friday, 21st May, 2021). Results of the clinical trial at the School ...
May 21, 2021
0
53
The common skin disease atopic eczema (AE) impacts heavily on the life quality and general health of sufferers. Researchers at Karolinska Institutet in Sweden have now evaluated its treatment with internet-delivered cognitive ...
May 19, 2021
0
36
Exposure to antibiotics in utero and during the first year of life is associated with an increased risk for atopic dermatitis, with the correlation partially attenuated after adjustment for familial factors, according to ...
May 5, 2021
0
6
Itch torments its sufferers and can be as debilitating as chronic pain.
Apr 30, 2021
0
57
Wildfire smoke can trigger a host of respiratory and cardiovascular symptoms, ranging from runny nose and cough to a potentially life-threatening heart attack or stroke. A new study suggests that the dangers posed by wildfire ...
Apr 21, 2021
0
68
Eczema, or atopic dermatitis (AD), is sometimes called "the itch that rashes." Often, the itch begins before the rash appears, and, in many cases, the itchiness of the skin condition never really goes away. Approximately ...
Apr 2, 2021
0
222
(HealthDay)—For moderate-to-severe atopic dermatitis, the oral Janus kinase 1 (JAK1) inhibitor abrocitinib at 200 mg or 100 mg once daily results in significantly greater reductions in signs and symptoms versus placebo, ...
Mar 25, 2021
0
4
